Available to sourceHuman Prescription DrugGastrointestinal

Sodium Chloride

234 mg/mL · Injection

By Fresenius Kabi USA, LLC

NDC: 63323-187
Route: Intramuscular; Intravenous; Subcutaneous
Therapeutic class: Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative
Marketing category: UNAPPROVED DRUG OTHER

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.